SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-21-000742
Filing Date
2021-08-12
Accepted
2021-08-12 17:05:27
Documents
14
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k-q2.htm   iXBRL 8-K 25232
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 91184
3 GRAPHIC image_001.jpg GRAPHIC 3169
  Complete submission text file 0001079973-21-000742.txt   308880

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE opgn-20210812.xsd EX-101.SCH 3015
5 XBRL LABEL FILE opgn-20210812_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE opgn-20210812_pre.xml EX-101.PRE 22352
7 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k-q2_htm.xml XML 3869
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 211168570
SIC: 8071 Services-Medical Laboratories